跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 31,465 条关于
“Jiangsu Hengrui Medicine Co. Ltd.”
全部
31,465
临床试验
8,366
药物
2,357
机构
4,856
资讯
15,886
去年
HER2-Positive Gastric Cancer Pipeline Shows Robust Activity with 20+ Companies Developing Novel Therapies
去年
Hengrui Medicine Advances Cancer Pipeline with Breakthrough Therapy Designations and Clinical Trial Approvals
去年
Comprehensive HER2+ Breast Cancer Clinical Trials Report 2025 Reveals Global Research Landscape
去年
Hyperuricemia Pipeline Shows Promise with 15+ Emerging Therapies in Development
去年
Advanced Renal Cell Carcinoma Pipeline Shows Strong Growth with 60+ Therapies in Development
去年
Chinese Drugmaker Jiangsu Hengrui Becomes World's Top Clinical Trial Sponsor as China Transforms Global R&D Landscape
去年
Eisai Advances LEQEMBI Subcutaneous and IV Maintenance Dosing Applications for Alzheimer's Disease
去年
AIM Vaccine Submits 13-Valent Pneumonia Conjugate Vaccine for Approval After Positive Phase III Results
去年
Hengrui Pharmaceuticals Aims to Raise $1.27 Billion in Hong Kong IPO
去年
Rege Nephro Secures $150 Million in Series B Funding to Advance Kidney Disease Therapies
第 1 页，共 1589 页
上一页
下一页
